Affiliation:
1. I.M. Sechenov First Moscow State Medical University (Sechenov University)
2. Clinical Center of Advanced Medical Technologies of the Federal Medical and Biological Agency
3. State Research Center – Burnasyan Federal Medical Biophysical Center of the Federal Medical and Biological Agency
4. Joint Stock Company "Medsi group"
5. Federal Scientific and Clinical Center for Specialized Methods of Medical Care and Medical Technologies of the Federal Medical and Biological Agency
6. Lomonosov Moscow State University Medical Research and Educational Center (Lomonosov University Clinic)
Abstract
Background: Laparoscopic surgery has proved itself to be a “golden standard” for treatment of most abdominal and retroperitoneal cancers. Such a serious procedure as pelvic exenteration continues to be a complex surgical intervention usually performed through a conventional laparotomic access. However, studies on minimally invasive approach for this intervention have becoming increasingly published in the world literature.Aim: To describe the laparoscopic pelvic exenteration technique of pelvic exenteration, as well as to assess short- and long-term results of these interventions.Materials and methods: From 2011 to 2018, 21 procedures of laparoscopic pelvic exenteration have been performed in 6 surgical centers (Moscow, Russia). Six (6) patients had previously confirmed cervical cancer, 7 patients had bladder cancer, 4 patients had rectal cancer, 1 patient had vaginal cancer, 2 patients had relapsing vaginal cancers after previous uterine extirpation, and 1 patient had an ovarian neoplasm.Results: The laparoscopic pelvic exenteration volumes were as follows: 9 total, 7 anterior and 5 posterior procedures. In 19 out of 21 cases, negative resection margin (R0) was possible. Median duration of the procedure was 254 minutes, median blood loss was 515 ml, and median postoperative hospital stay was 13 days. Postoperative complications were registered in 6 (28.6%) patients. The 3-year overall survival was 85.71%.Сonclusion: The choice of laparoscopic access can reduce blood loss, decrease the rates of early postoperative complications, contributes to a more comfortable postoperative period with early activation and less severe pain syndrome, and leads to a reduction in the duration of hospital stay. These results of the laparoscopic technique are comparable with those of laparoscopic and open pelvic exenteration published by other authors.
Publisher
Moscow Regional Research and Clinical Institute (MONIKI)
Reference23 articles.
1. American Cancer Society. Cancer Fact & Figures 2017. Atlanta: American Cancer Society; 2017 [Internet]. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2017/cancerfacts-and-figures-2017.pdf.
2. Jayne DG, Thorpe HC, Copeland J, Quirke P, Brown JM, Guillou PJ. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg. 2010;97(11): 1638–45. doi: 10.1002/bjs.7160.
3. PelvEx Collaborative. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer. Br J Surg. 2018;105(6): 650–7. doi: 10.1002/bjs.10734.
4. Latypov VR, Dambaev GTs, Popov OS, Vusik AN. Results of pelvic exenteration in a woman for cancers and radiotherapy complications. Cancer Urology. 2015;11(1): 55–63. Russian. doi: 10.17650/1726-9776-2015-1-5563.
5. Kostyuk IP, Shestaev AYu. Pelvic evisceration as the method of choice in the treatment of recurrent cervical cancer. Vestnik of Russian Military Medical Academy. 2012;(1): 280–5. Russian.